Vitiligo treated with topical corticosteroids: Children with head and neck involvement respond well [4]

Journal of the American Academy of Dermatology

Volumn 46, Issue 6, 2002, Pages 964-965

  Cockayne, Sarah E ^a   Messenger, Andrew G ^a   Gawkrodger, David J ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FLUOCINOLONE ACETONIDE; FLUOCINONIDE; FLUTICASONE PROPIONATE; HYDROCORTISONE; HYDROCORTISONE BUTYRATE; MOMETASONE FUROATE;

ADULT; CHILD; CLINICAL FEATURE; CONVALESCENCE; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG RESPONSE; HEAD AND NECK DISEASE; HUMAN; LETTER; ONSET AGE; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PRIORITY JOURNAL; PUVA; RETROSPECTIVE STUDY; SKIN COLOR; SYMPTOM; UNITED KINGDOM; VITILIGO;

EID: 0036622045     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.120576     Document Type: Letter

References (4)

1. Porter J, Beuf AH, Lerner AB, Nordlund JJ. Response to cosmetic disfigurement: patients with vitiligo. Cutis 1987;39:493-4.
2. Njoo MD, Spuls PI, Bos JD, Westerhof W, Bossuyt PMM. Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature. Arch Dermatol 1998;134:1532-40.
3. Kovacs SO. Vitiligo. J Am Acad Dermatol 1998;38:647-66.
4. Koga M. Vitiligo: a new classification and therapy. Br J Dermatol 1977;97:255-61.